BVCF (Bioveda China Fund)

Beijing
Founded:2005
Firm Location:Beijing • China • Shanghai
BVCF (Bioveda China Fund) Team
Photo of Jadium Chen, Managing Director at BVCF (Bioveda China Fund)
Jadium Chen
BVCF (Bioveda China Fund)·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Yunlong Huang, Managing Director at BVCF (Bioveda China Fund)
Yunlong Huang
BVCF (Bioveda China Fund)·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Vanessa Huang, General Partner at BVCF (Bioveda China Fund)
Vanessa Huang
BVCF (Bioveda China Fund)·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Robert Li, Partner at BVCF (Bioveda China Fund)
Robert Li
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Yong Wang, Investor at BVCF (Bioveda China Fund)
Yong Wang
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Yongli Wang, Partner at BVCF (Bioveda China Fund)
Yongli Wang
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Huacheng Wei, General Partner at BVCF (Bioveda China Fund)
Huacheng Wei
BVCF (Bioveda China Fund)·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of YuChao Xu, Principal at BVCF (Bioveda China Fund)
YuChao Xu
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Zhi Yang, Managing Partner at BVCF (Bioveda China Fund)
Zhi Yang
BVCF (Bioveda China Fund)·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Rachel Zhao, Principal at BVCF (Bioveda China Fund)
Rachel Zhao
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness
Photo of Bing Zhuo, Investor at BVCF (Bioveda China Fund)
Bing Zhuo
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Shanghai
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in FinTech, Investors in Health IT, Investors in Pharmaceuticals, Investors in Wellness & Fitness